StockTipsArenaBeta

BUY Torrent Pharmaceuticals Limited — HSBC Securities

BUYTorrent Pharmaceuticals Limited
Torrent Pharmaceuticals share price target & all analyst calls

byHSBC SecuritiesHorizon: NA (inferred 1 year)7 Oct 2026via Zee Business (Live)

Entry₹4,765Inferred
Target₹5,680
Total upside +19.20%
Stop lossNot given
CMP₹4,617.13h ago
Active-3.10%+23.02%upside left 12 mo left
Follow HSBC Securities for new calls(100% target hit, 14 closed calls)Get alertsWatch TORNTPHARM for new buy/sell callsGet alertsSee 2 other Long-term calls on TORNTPHARMSee 105 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 8 Oct, 7:54 pm IST
14 supporting4 neutral4 opposing
Supports the BUY call (14)

India Ratings and Research has affirmed the company's credit rating at IND AA+ and revised the outlook from stable to positive for its banking facilities, issuer rating, and non-convertible debentures

BSE · Company Update·7 Oct · yesterday

(opens in new tab)

Long-term trend bullish — 200-day average rising over the past quarter

Technicals · trend·7 Oct · yesterday

1 advisor has an active short-term BUY call on this stock, issued in the last 14 days

Advisor consensus · adjacent horizon·29 Sept · 1w ago

Torrent Pharmaceuticals stock reports 54.6 percent sales growth

NewsGoogle News·25 Sept · 2w ago

(opens in new tab)

2 other SEBI-registered advisors have active long-term BUY calls on this stock

Advisor consensus · same horizon·3 Aug · 2mo ago

Neutral / worth noting (4)

Q2 FY27 results scheduled — board meets 23 Oct 2026

BSE · Board Meeting·In 14 days

(opens in new tab)
Weighs against the BUY call (4)

Torrent Pharma stock gains as August volume growth turns negative

NewsGoogle News·20 Sept · 3w ago

(opens in new tab)

Torrent recalls select Semalix injection disposable pens

NewsGoogle News·9 Sept · 4w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Torrent Pharmaceuticals

All analyst calls on Torrent Pharmaceuticals

More from HSBC Securities

Every call and its outcome